Sciele Pharma Inc. v. Lupin Ltd.

Procedural entryThis page is a short order in Sciele Pharma Inc. v. Lupin Ltd.. Read the opinion of the Court — 684 F.3d 1253
Court of Appeals for the Federal Circuit·Decided July 12, 2012·No. 2012-1228·Published

Opinion

United States Court of Appeals for the Federal Circuit

July 12, 2012

ERRATA

2012-1228

SCIELE PHARMA INC. (now known as Shionogi Pharma Inc.), Plaintiff-Appellee,

and

ANDRX CORPORATION, ANDRX PHARMACEUTICALS INC. (doing business as Watson Laboratories Inc. - Florida), ANDRX PHARMACEUTICALS L.L.C., ANDRX LABORATORIES (NJ) INC.,

ANDRX EU LTD., and ANDRX LABS L.L.C.,

Plaintiffs,

v.

LUPIN LTD. and LUPIN PHARMACEUTICALS INC., Defendants-Appellants,

and

MYLAN INC. and MYLAN PHARMACEUTICALS INC.,

Defendants.

Decided July 2, 2012

Precedential Order

Please make the following change:

Page 2, correct name “Douglas C. Hochstetler” to “Douglass C. Hochstetler”

Free access — add to your briefcase to read the full text and ask questions with AI

Sciele Pharma Inc. v. Lupin Ltd., (Fed. Cir. 2012).

Sciele Pharma Inc. v. Lupin Ltd. (Sciele Pharma Inc. v. Lupin Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.